Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Maxcyte Inc

MXCT
323,00
0,00 (0,00%)
Ultimo aggiornamento: 09:00:20
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
19/12/202417:26LSEG_RNSMaxCyte, Inc. Holding(s) in Company
18/12/202416:31LSEG_RNSMaxCyte, Inc. Holding(s) in Company
10/12/202418:16LSEG_RNSMaxCyte, Inc. Holding(s) in Company
10/12/202418:12LSEG_RNSMaxCyte, Inc. Holding(s) in Company
09/12/202413:29ALNCNewsMaxCyte ups core revenue guidance for 2024 as eyes 2025 cost..
09/12/202408:00LSEG_RNSMaxCyte, Inc. MaxCyte Streamlines Operations and Raises..
09/12/202408:00GLOBEMaxCyte Announces Streamlined Operations and Raises 2024..
02/12/202418:09LSEG_RNSMaxCyte, Inc. Total Voting Rights and Block Listing Return
28/11/202416:05LSEG_RNSMaxCyte, Inc. Holding(s) in Company
28/11/202416:05LSEG_RNSMaxCyte, Inc. Holding(s) in Company
19/11/202410:49LSEG_RNSMaxCyte, Inc. Holding(s) in Company
13/11/202414:05GLOBEMaxCyte Celebrates 25 Years of Innovation Driving Cell..
08/11/202415:41ALNCNewsMaxCyte third-quarter profit falls amid surging costs
07/11/202408:00LSEG_RNSMaxCyte, Inc. Filing of 10Q form
07/11/202408:00LSEG_RNSMaxCyte, Inc. Third Quarter 2024 Financial Results
06/11/202422:05GLOBEMaxCyte Reports Third Quarter 2024 Financial Results and..
06/11/202422:05UKREGMaxCyte Reports Third Quarter 2024 Financial Results and..
06/11/202414:43LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
04/11/202414:23LSEG_RNSMaxCyte, Inc. Total Voting Rights
31/10/202413:05GLOBEMaxCyte to Participate in Two Upcoming Investor Conferences
31/10/202413:05LSEG_NONMaxCyte, Inc. Upcoming Investor Conferences
31/10/202408:00LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
18/10/202410:24LSEG_RNSMaxCyte, Inc. Grant of Options and Restricted Stock Units
15/10/202414:05LSEG_RNSMaxCyte, Inc. MaxCyte Appoints Cynthia Collins to Board
15/10/202414:05GLOBEMaxCyte Appoints Cynthia Collins to its Board of Directors
11/10/202414:05GLOBEMaxCyte to Report Third Quarter 2024 Financial Results on..
11/10/202414:00LSEG_RNSMaxCyte, Inc. Notice of Results
10/10/202414:05LSEG_RNSMaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCO
10/10/202414:05GLOBEMaxCyte Appoints Ali Soleymannezhad as Chief Commercial..
03/10/202410:41LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
01/10/202410:47LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
01/10/202408:00LSEG_RNSMaxCyte, Inc. Total Voting Rights
27/9/202417:15LSEG_RNSMaxCyte, Inc. Holding(s) in Company
27/9/202416:29LSEG_RNSMaxCyte, Inc. Holding(s) in Company
20/9/202418:02LSEG_RNSMaxCyte, Inc. Holding(s) in Company
16/9/202411:33ALNCNewsMaxCyte touts strategic platform license deal with Kamau..
16/9/202408:00LSEG_RNSMaxCyte, Inc. TR-1: Notification of major holdings
16/9/202408:00LSEG_RNSMaxCyte, Inc. Signing of Strategic Platform License
16/9/202408:00GLOBEMaxCyte Signs Strategic Platform License with Kamau..
06/9/202418:07LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
06/9/202412:33LSEG_NONMaxCyte, Inc. Bioprocessing Conference Participation
05/9/202422:05GLOBEMaxCyte to Participate in Virtual Craig-Hallum Capital Group..
03/9/202416:38LSEG_RNSMaxCyte, Inc. Total Voting Rights
29/8/202411:06LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
07/8/202415:10ALNCNewsMaxCyte reaffirms guidance as revenue jumps 24% in first..
07/8/202408:05LSEG_RNSMaxCyte, Inc. Filing of Form 10-Q
07/8/202408:00LSEG_RNSMaxCyte, Inc. Second Quarter and Half-Year Results
06/8/202422:05GLOBEMaxCyte Reports Second Quarter and Half-Year 2024 Financial..
01/8/202417:31LSEG_RNSMaxCyte, Inc. Total Voting Rights
31/7/202408:00LSEG_RNSMaxCyte, Inc. Exercise of options and PDMR dealing
Apertura: 323,00 Min: 320,00 Max: 323,00
Chiusura: 323,00

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network